Registry of Lobbyists

Registration - In-house Organization

Multiple Sclerosis Society of Canada / Societe canadienne de la sclerose en plaques / Pamela Valentine, President & CEO

Registration Information

In-house Organization name: Multiple Sclerosis Society of Canada / Societe canadienne de la sclerose en plaques
Previous in-house organization names
Responsible Officer Name: Pamela Valentine, President & CEO 
Responsible Officer Change History
Initial registration start date: 2007-03-23
Registration status: Active
Registration Number: 935976-14937

Associated Communications

Total Number of Communication Reports: 627

Monthly communication reports in the last 6 months: 5

Version 2 of 54 (2007-10-18 to 2008-05-16)

Version 2 of 54 (2007-10-18 to 2008-05-16) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Organization Information

Organization: Multiple Sclerosis Society of Canada
175 Bloor St. E., Suite 700
Toronto, ON  M4W 3R8
Telephone number: 416-967-3007
Responsible officer name and position during the period of this registration: Yves Savoie, President & Chief Executive  
Description of the organization's activities: The Multiple Sclerosis Society of Canada is a health charity that supports research to find the cause, prevention and cure for MS, provides services and programs for persons with MS and their families and caregivers, and educates the public about the disease.
Organization's membership or classes of membership: The MS Society has approximately 28,000 members who join the organization through their local chapters or division offices.
Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No

B. Lobbyists Employed by the Organization

Name: Deanna Groetzinger
Position title: Vice-President, Government Relations and Policy
Public offices held: No
Name: Yves Savoie
Position title: President and Chief Executive
Public offices held: No

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Canadian Heritage (PCH), Canadian Transportation Agency (CTA), Finance Canada (FIN), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Human Resources and Social Development Canada (HRSDC), Human Resources Development Canada (HRDC), Industry Canada, Members of the House of Commons, Office of the Information and Privacy Commissioner (OIPC), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Revenue Canada (RC), Senate of Canada, Service Canada (ServCan), Transport Canada (TC), Treasury Board Of Canada Secretariat (TBS)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
Subject Matter: Areas of Concern: Disability issues, Employment and Training, Health, Science and Technology, Taxation and Finance
Subject Matter: Retrospective: Disability Tax Credit, Canada Pension Plan-Disability benefits, Employment Insurance sickness benefits, pharmaceutical stragegy, charitable tax receipting, health - home care and caregivers, Canadians with disabilities, Canadian Institutes of Health Research.
Subject Matter: Prospective: Episodic disabilities regarding Canada Pension Plan-Disability benefits,disability tax credit, Employment Insurance sickness benefits and Registered Disability Savings Plan; income tax regarding medical deductions; charitable tax receipting; health regarding home care and caregivers; Common Drug Review, Canadian Institutes of Health Research.

Details Regarding the Identified Subject Matter

Categories Description
Policy or Program Charitable tax receipting requirements
Policy or Program Common Drug Review and public input
Policy or Program Health care regarding home care and health of caregivers
Grant, Contribution or Other Financial Benefit Increased funding for the Canadian Institutes of Health Research
Policy or Program Pharmaceutical strategy
Policy or Program Sickness and disability benefits, tax measures for persons with chronic and episodic disabilities